Partially resorbable acrylic bone cements based on self-curing acrylic/phosphate glass formulations

Current acrylic bone cements are primarily non-resorbable, limiting their adaptability to biological environments. Prior research has shown that poly(methyl methacrylate) (PMMA) cements provide structural support but lack degradation properties. This gap motivated investigations into partially resorbable alternatives. It was already known that PMMA cements have high compressive strength but limited long-term biocompatibility. No prior work had resolved the challenge of balancing mechanical performance with controlled resorption. Researchers have explored phosphate glasses for their bioactive potential, but their integration into PMMA systems remained unverified. This study aimed to address whether phosphate glass could be incorporated into PMMA without compromising mechanical integrity. The field lacked evidence on how such composites behave under dynamic loading and in wet biological conditions. This uncertainty drove the need to evaluate both static and dynamic mechanical properties of PMMA/phosphate glass composites.

The aim of this study was to develop and evaluate the properties of partially resorbable acrylic bone cements using PMMA and phosphate glass composites. The specific problem addressed was whether the addition of phosphate glass could maintain mechanical performance while introducing controlled resorption. The motivation stemmed from the need for bone cements that degrade in sync with tissue regeneration. Researchers proposed that incorporating phosphate glass could offer a solution to the rigidity and non-degradability of traditional PMMA cements. The study sought to test whether these composites could meet international standards for bone cement performance. It was hypothesized that the presence of phosphate glass would not significantly alter the mechanical properties of PMMA. The researchers also aimed to assess how these composites behave under fatigue conditions typical in orthopedic applications. This work sought to bridge the gap between non-degradable PMMA and fully resorbable alternatives.

The study involved preparing PMMA/phosphate glass composites by varying the weight percentage of phosphate glass (20-60 wt-%) in the PMMA matrix. The formulations were mixed using methyl methacrylate monomer and PMMA powder. The curing process was monitored for temperature changes and setting time. Mechanical properties were assessed using static compression tests on both dry and wet specimens. Dynamic mechanical behavior was evaluated through fatigue crack propagation tests. The study compared the results of the PMMA/BV11 composites with a control PMMA formulation. The compressive yield strength was measured to determine compliance with ISO 5833 standards. The wear damage was tested using a UHMWPE/Ti6Al4V pair to simulate clinical conditions. This approach allowed the researchers to evaluate both structural and functional performance of the composites.

The PMMA/BV11 composites showed a 10°C reduction in maximum curing temperature and a 10-minute increase in setting time. The residual monomer content remained unchanged across all formulations. The glass transition temperature of the composites was not significantly affected by the addition of phosphate glass. Dry specimens of PMMA/BV11 composites had compressive yield strengths between 110-118 MPa. Wet specimens showed reduced strength due to dissolution of the phosphate glass. However, composites with 20 or 40 wt-% BV11 met the ISO 5833 standard for acrylic bone cements. The fatigue crack propagation tests followed the Paris-Erdogan model with no significant differences in the exponent m. The presence of phosphate glass did not alter the wear damage in UHMWPE/Ti6Al4V pairs.

The authors proposed that PMMA/phosphate glass composites can maintain mechanical performance while introducing partial resorption. The study found that the addition of phosphate glass reduced curing temperature and increased setting time without affecting residual monomer levels. The composites with 20 or 40 wt-% BV11 met international standards for compressive strength in dry conditions. Wet testing revealed a strength decrease due to glass dissolution, but this did not compromise compliance with ISO 5833. The fatigue behavior of the composites followed the Paris-Erdogan model with no significant differences in crack propagation exponents. The researchers observed that phosphate glass did not alter wear damage in UHMWPE/Ti6Al4V pairs. These findings suggest that PMMA/BV11 composites are viable candidates for partially resorbable bone cements. The authors suggest that these materials could offer improved biocompatibility without sacrificing structural integrity.